Surmodics | SRDX - 負債





負債 変化する 日付
Abbott USD 12.94B 496M 2025-09
Align Technology USD 121.27M 1.75M 2025-09
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 366.28M 13.25M 2025-09
Artivion USD 317.78M 619K 2024-12
Baxter International USD 9.71B 13M 2025-09
Boston Scientific USD 12.05B 19M 2025-09
EDAP TMS EUR 7.55M 1.41M 2025-09
Edwards Lifesciences USD 700.3M 2.3M 2025-09
Haemonetics USD 1.22B 54K 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
J&J USD 45.8B 4.97B 2025-09
Merit Medical Systems USD 821.15M 599K 2025-09
Mesa Laboratories USD 204.98M 7.27M 2024-09
Nektar Therapeutics USD 0 0 2022-06
Option Care Health USD 1.15B 1M 2025-12
Stryker USD 14.86B 1.74B 2025-12
Surmodics USD 29.55M 111K 2024-09
Trinity Biotech USD 100.76M 7.05M 2024-12